Reactive oxygen species (ROS)-based nanocatalytic cancer therapy is hindered by insufficient substrates at the tumor site and potential side effects arising from metabolites. Here the authors report a violet phosphorus-based nanosystem that supplies catalysts and substrates for producing cytotoxic ROS and generates the degradation products that can promote tumor calcification.
- Hanjie Zhang
- Yitong Zhang
- Lin Mei
